Skip to search formSkip to main contentSkip to account menu

Bispecific Human Anti-ANG-2/Anti-VEGF-A Antibody RO5520985

Known as: Ang2-VEGF-A CrossMab RO5520985, RG7221, RO5520985 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Purpose:VEGF-A blockade has been clinically validated as a treatment for human cancers. Angiopoietin2 (Ang-2) expression has been…